Specialty Ophthalmology
-
Featured
Researchers Find Potential Path to a Broadly Protective COVID-19 Vaccine Using T cells
Gaurav Gaiha, MD, DPhil, and Elizabeth Rossin, MD, PhD, use structure-based network analysis to confirm predictions about the potential for a T cell vaccine that provides protection against existing variants, such as the Delta variant, and future SARS-CoV-2 variants.
-
Featured
Using Artificial Intelligence to Diagnose Glaucoma
David S. Friedman, MD, PhD, MPH, a clinician-scientist and director of the Glaucoma Service in the Department of Ophthalmology, discusses the implementation of artificial intelligence in the detection of glaucoma in screening with photographs.
-
Featured
Potential Treatment Targets Identified for Age-Related Macular Degeneration
By assessing genomic–metabolomic associations in age-related macular degeneration, Deeba Husain, MD, of the Department of Ophthalmology, and colleagues have obtained additional evidence of the pathogenic role of the LIPC gene and glycerophospholipid metabolism, which may represent novel treatment targets.
-
Compassionomics: The Science and Practice of Caring
Inês Laíns, MD, PhD, and colleagues summarize the robust scientific evidence that compassion can measurably improve patient outcomes and the well-being of healthcare providers. They outline strategies for measuring compassion, and to train and cultivate compassionate care.
-
The Neuropeptide Alpha-Melanocyte–stimulating Hormone Prevents Persistent Corneal Edema After Injury
Reza Dana, MD, MSc, MPH; Jia Yin, MD, PhD, MPH; Ula V. Jurkunas, MD; and colleagues have discovered a critical role for neuropeptides in maintenance of corneal endothelial cells and potential therapeutic applications for α-melanocyte–stimulating hormone after corneal injury or intraocular surgery.
-
Integrated Genomic Analysis Prioritizes Causal Genes and Cell Types for Glaucoma
Ayellet V. Segrè, PhD, MSc, and colleagues integrated multiple genetic and functional genomic datasets and identified regulatory mechanisms, genes, pathways and cell types that may play an important role in the etiology of primary open-angle glaucoma and become targets for novel therapies.
Ophthalmology Contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
John B. Miller, MD
Clinician–Investigator, Yeatts Retina Research Laboratory, Mass Eye and Ear, Member, Diabetic Eye Disease Center of Excellence, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Review: Telemedicine for Diagnosis and Management of Age-Related Macular Degeneration
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Younger Age, Albuminuria Linked to Advanced Diabetic Retinopathy in South India
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Tobias Elze, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Usage Patterns of Minimally Invasive Glaucoma Surgery Differ by Glaucoma Type
-
Ula V. Jurkunas, MD
Associate Director, Cornea Service, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School
Recent Article
The Neuropeptide Alpha-Melanocyte–stimulating Hormone Prevents Persistent Corneal Edema After Injury
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
